Decreased circulating CD34+ cells are associated with progression of diabetic nephropathy: Short Report

Diabetic Medicine

Volumn 26, Issue 2, 2009, Pages 171-173

  Makino, H ^a   Okada, S ^a   Nagumo, A ^a   Sugisawa, T ^a   Miyamoto, Y ^a   Kishimoto, I ^a   Kikuchi Taura, A ^b   Soma, T ^b   Taguchi, A ^a   Yoshimasa, Y ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b MINAMI OSAKA GENERAL HOSPITAL   (Japan)

Author keywords

Albuminuria; Endothelium; Microangiopathy

Indexed keywords

ALBUMIN; CD34 ANTIGEN;

ADULT; AGED; ARTICLE; DIABETIC NEPHROPATHY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NEOVASCULARIZATION (PATHOLOGY); NON INSULIN DEPENDENT DIABETES MELLITUS; VASCULAR ENDOTHELIUM;

ADULT; AGED; ALBUMINURIA; ANTIGENS, CD34; CELL COUNT; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; STEM CELLS;

EID: 60049087528     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2008.02638.x     Document Type: Article

References (10)

1. Fadini GP, Miorin M, Facco M, Bonamico S, Baesso I, Grego F et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 2005 45 : 1449 1457.
2. Fadini GP, de Kreutzenberg SV, Coracina A, Baesso I, Agostini C, Tiengo A et al. Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk. Eur Heart J 2006 27 : 2247 2255.
3. Taguchi A, Soma T, Tanaka H, Kanda T, Nishimura H, Yoshikawa H et al. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 2004 114 : 330 338.
4. Kikuchi-Taura A, Soma T, Matsuyama T, Stern DM, Taguchi A. A new protocol for quantifying CD34(+) cells in peripheral blood of patients with cardiovascular disease. Tex Heart Inst J 2006 33 : 427 429.
5. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Hara S et al. Modification of the modification of diet in renal disease (MDRD) study equation for Japan. Am J Kid Dis 2007 50 : 927 937.
6. Pistrosch F, Herbrig K, Kindel B, Passauer J, Fischer S, Gross, P. Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients. Diabetes 2005 54 : 2206 2211.
7. Uchimura H, Marumo T, Takase O, Kawachi H, Shimizu F, Hayashi M et al. Intra renal injection of bone marrow-derived angiogenic cells reduces endothelial injury and mesangial cells activation in experimental glomerulonephritis. J Am Soc Nephrol 2005 16 : 997 1004.
8. Makino H, Miyamoto Y, Sawai K, Mori K, Mukoyama M, Nakao K et al. Altered gene expression related to glomerulogenesis and podocyte structure in early diabetic nephropathy of db/db mice and its restoration by pioglitazone. Diabetes 2006 55 : 2747 2756.
9. Lee IG, Chae SL, Kim JC. Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of DR. Eye 2006 20 : 546 552.
10. Baelde HJ, Eikmans M, Doran PP, Lappin DWP, de Heer E, Bruijn JA. Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy. Am J Kid Dis 2004 43 : 636 650.